Navigation Links
Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
Date:7/21/2009

ALEXANDRIA, Va., July 21 /PRNewswire/ -- The Global Probiotics Council (GPC), a committee established in 2004 by DANONE and Yakult Honsha Co., Ltd., announced the two recipients of the annual Young Investigator Grant for Probiotics Research (YIGPRO) today. The program was created to identify young rising stars who will continue to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States. This year, the grant focus is on the role of probiotics in health and disease.

Glynis L. Kolling, PhD, an Instructor in the Department of Medicine, Division of Infectious Diseases and International Health at the University of Virginia was selected for her research proposal, "The Influence of Novel Oligopeptides Produced by Transgenic Bacteria on Intestinal Injury Due to C. difficile Infection." After certain inflammatory conditions, drug treatments, or infections, human gut microbiota can become unbalanced. This research will focus on creating a bacterial delivery system that will promote intestinal repair and restore the balance of normal microbiota. Dr. Kolling's work could help patients who experience antibiotic-associated diarrhea (AAD) after receiving antibiotic treatment.

The other grant will be awarded to Xinhua Chen, PhD, who is an Instructor in Medicine at Harvard Medical School, Beth Israel Deaconess Medical Center. His proposal is titled "Protective Role of Baker's Yeast in Colonic Inflammation and Cancer." This study could make an important contribution in understanding the mechanisms by which yeast, which has been used for centuries for the production of fermented foods, may prove to be preventative or therapeutic in fighting intestinal inflammation and colon cancer. The GI tract has an extremely complicated ecosystem and Dr. Chen's work should contribute to the growing understanding of the mechanisms on how probiotics work in GI disorders.

The Global Probiotics Council (GPC) was extremely pleased with the outstanding quality of the applications received for the second year of this grant. A rigorous review and evaluation of all the applications was provided by the U.S. Probiotics Scientific Board Selection Committee, which is comprised of W. Allan Walker, MD, Conrad Taff Professor of Nutrition at Harvard Medical School, Mary Ellen Sanders, PhD, Executive Director, International Scientific Association for Probiotics and Prebiotics (ISAPP), Richard Guerrant, MD, Director, Center for Global Health, University of Virginia School of Medicine and Balfour Sartor, MD, Distinguished Professor of Medicine, Microbiology, and Immunology, University of North Carolina at Chapel Hill. "We were very impressed with the high caliber of science in the applications received," said Dr. Walker, Chair of the Committee.

The GPC, established by DANONE and Yakult Honsha Co., Ltd. is committed to raising awareness of probiotics and their health benefits through science-based education. The Young Investigator Grant for Probiotics Research was created in 2008 to stimulate innovative research relevant to the field of gastrointestinal microbiota, to support young investigators in the United States, to attract them into the field of probiotics, and to provide preliminary data for future funding from NIH and other funding sources. The global advancement in this growing research field is a key to understanding how probiotic food might contribute to good health in all ages.

"Each year, promising new evidence on the benefits of probiotics on human health continues to emerge," said Sven Thormahlen, Executive Vice President R&D, Danone Research. "We hope the two young investigators will advance our knowledge in the growing field of probiotics and provide insight to better understanding the full potential of 'friendly' microorganisms and the mechanisms in which they promote human health."

"We are very pleased with the direction and success of this program. We hope this grant will continue to increase interest and raise awareness of probiotics among young researchers in the United States," says Mr. Yoshihiro Kawabata, Senior Managing Director, Yakult Honsha Co., Ltd.

The Global Probiotics Council will provide $50,000 over the course of one year to both Drs. Chen and Kolling and their respective institutions.

Additional details and future announcements on the Young Investigator Grant for Probiotics Research program can be found at www.probioticsresearch.com.

The Global Probiotics Council (GPC) was established in 2004 through a collaborative agreement between DANONE and Yakult Honsha Co., Ltd. The role of the GPC is to promote and/or advance probiotics in the world, through means such as:

  1. Raising awareness of probiotics and their health benefits through science-based education and dissemination of information to health care professionals and the public;
  2. Communicating with government bodies, and other relevant interest groups; and
  3. Building relationships with leading researchers and research institutions and supporting collaboration research in the area of probiotics and intestinal microbiota.

GPC activities began with the establishment of the Probiotics Scientific Board in the United States. The Young Investigator Grant for Probiotics Research program was established to meet these goals by contributing to the advancement of probiotics study in the United States.

DANONE is the world's leading producer of yogurt products. These products are sold under the DANNON and DANONE brand names. Since its foundation, DANONE has built its business on product offerings which combine health benefits and taste. DANONE RESEARCH is the organization responsible for all DANONE R&D activities (1200 employees worldwide). Its mission is to formulate DANONE products with health benefits based on scientific evidence. It also studies the effects of food on health and aims to continuously improve the nutritional profile of DANONE products worldwide.

Probiotic research is a key expertise of DANONE RESEARCH. Over the past 90 years, DANONE has amassed a collection of approximately 3,500 lactic bacteria strains or "cultures." In addition to taste and texture, some of these cultures provide probiotic health properties. Such is the case of Bifidobacterium animalis DN 173 010, used to produce Activia, and Lactobacillus casei DN 114 001, used to produce DanActive. Because this culture collection holds considerable potential for product innovation, DANONE RESEARCH using state-of-the-art technologies such as genomics and robotics to select the probiotic bacteria of the future is carefully studying it. For more information, please visit www.danone.com/?lang=en, www.danone.com/en/research-innovations.html, www.dannon.com.

Yakult Honsha Co., Ltd., headquartered in Tokyo, Japan, is the world's pioneer in probiotics by introducing the first single shot probiotics drink, Yakult((R)), in 1935. Founded by microbiologist Dr. Minoru Shirota, Yakult((R)) contains high amounts of its signature strain, Lactobacillus casei Shirota. Yakult is committed to researching the endless applications for probiotics and the role of intestinal bacteria in human health around the world. The company has established two science institutes to support its efforts: one in Japan (Yakult Central Institute for Microbiological Research) and one in Europe (Yakult Honsha European Research Center for Microbiology ESV). Since developing its overseas network in 1964, Yakult has expanded its business to 32 countries and regions. In addition to producing the internationally recognized probiotic beverage, Yakult is also accredited in the pharmaceutical field for its development of Campto Injection (Camptosar), the first-line drug for colorectal cancer in the U.S. Yakult U.S.A. Inc., the subsidiary of Yakult Honsha Co., Ltd., is stationed in Torrance, CA. For more information, please visit http://www.yakult.co.jp/english, http://www.yakult.co.jp/institute, http://www.yakultusa.com .


'/>"/>
SOURCE Yakult Honsha Co., Ltd.; DANONE
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Younger Adults Increasingly Treated for Heart Disease-related Conditions
2. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
3. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
4. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia
5. St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
6. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
8. Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
9. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
10. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
11. Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):